Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.

Ortho Clinical Diagnostics Holdings plc

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Michael Boyd

Sonic Healthcare Limited

Genomic Health, Inc. was a company focusing on genetic research specifically in cancer detection, based out of Redwood City, California. The company developed Oncotype DX, a genomic assay that quantified the likelihood of breast cancer recurrence.

Randy Scott

Genomic Health, Inc.

SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.

SYNLAB AG

QuidelOrtho specializes in diagnostic solutions, transforming diagnostic data into actionable health information. The company provides a range of products and services targeting healthcare providers and laboratory professionals.

Metric
Company Name	Ortho Clinical Diagnostics Holdings plc	Sonic Healthcare Limited	Genomic Health, Inc.	SYNLAB AG
Symbol	OCDX	SHL		SYAB
MSH ID	COM:ORTHOCLINICALDIAGNOSTICS	COM:SONICHEALTHCARE	COM:GENOMICHEALTH	COM:SYNLAB
Market	STOCKS	STOCKS	PRIVATE	STOCKS
Sector	Healthcare	Healthcare	Healthcare	Healthcare
Industry	Medical - Diagnostics & Research	Medical - Diagnostics & Research	Genomics	Medical - Diagnostics & Research
Country	US	AU	US	DE
Stage
Employee Count	4.80K	41K	336	27K
Website	orthoclinicaldiagnostics.com	sonichealthcare.com	genomichealth.com	synlab.com
LinkedIn			genomic-health
Founders

Metric
Market Cap	7.93B		2.56B
Enterprise Value
Monthly Web Traffic		89	2.46K
Web Traffic Growth		1.01	-0.63
Valuation
Raised Capital

Metric
Revenue	2.04B	5.53B	2.78B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.04B	1.31B	2.78B
EBITDA	253.40M	864.20M	212.94M
Operating Income	120M	367.53M	62.53M
Net Income	-54.30M	326.57M	97.49M
EPS	-0.23	0.68
Diluted EPS	-0.22	0.68	0.44
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.51	0.25	0.76
Operating Profit Margin	0.06	0.08	0.11
EBITDA Margin	0.12	0.16	0.08
Net Profit Margin	-0.03	0.06	0.05
Return on Equity	0.18	0.07	0.08
Return on Assets	-0.02	0.04	0.03
Return on Capital Employed	0.04	0.05	0.07

OCDX

COM:ORTHOCLINICALDIAGNOSTICS

QuidelOrtho

Last Close

17.47

01/01 00:00

Volume Today

789.49K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-76.49	22.01	20.31
P/B Ratio	10.12	1.95	1.09
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		1.66	0.94
EV Multiple	-7.66	7.52	2.57

Metric
Days Sales Outstanding	45.96	45.67	55.93
Days Payables Outstanding	65.62	65.78	156.08
Days Inventory Outstanding	110.72	12.57	39.34
Operating Cycle	156.67	68.95	95.27
Cash Conversion Cycle	91.05	9.59	-1.83
Asset Turnover	0.61	0.60	0.57

Metric
Operating Cash Flow	286.60M	684.66M	306.73M
Free Cash Flow	286.60M	314.38M	158.61M
Cash Flow to Debt	0.13	0.39	0.36
Operating Cash Flow/Sales	0.14	0.14	0.15
Free Cash Flow Yield		0.07	0.05

Metric
Cash & Equivalents	309.70M	412.14M	233.98M
Accounts Receivable			32.27M
Inventory	305.40M	133.44M	68.69M
Goodwill	573.60M		2.32B
Debt to Capitalization	0.85	0.30	0.42
Debt to Assets	0.67	0.24	0.35
Current Ratio	1.75	1.14	1.45
Quick Ratio	0.98	0.92	1.21

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.00	0.00
R&D to Revenue	0.06
SG&A to Revenue			0.11